Leavell Investment Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.93M | Buy |
5,835
+524
| +10% | +$252K | 0.11% | 182 |
|
|
2026
Q1 | $2.61M | Hold |
5,311
| – | – | 0.11% | 186 |
|
|
2025
Q4 | $3.08M | Sell |
5,311
-125
| -2% | -$70.7K | 0.13% | 170 |
|
|
2025
Q3 | $2.64M | Sell |
5,436
-341
| -6% | -$159K | 0.11% | 186 |
|
|
2025
Q2 | $2.34M | Sell |
5,777
-218
| -4% | -$91.1K | 0.11% | 191 |
|
|
2025
Q1 | $2.99M | Sell |
5,995
-201
| -3% | -$109K | 0.15% | 150 |
|
|
2024
Q4 | $3.23M | Sell |
6,196
-196
| -3% | -$108K | 0.16% | 142 |
|
|
2024
Q3 | $3.96M | Sell |
6,392
-63
| -1% | -$37.3K | 0.2% | 115 |
|
|
2024
Q2 | $3.57M | Buy |
6,455
+500
| +8% | +$286K | 0.2% | 116 |
|
|
2024
Q1 | $3.46M | Buy |
5,955
+58
| +1% | +$32.5K | 0.2% | 115 |
|
|
2023
Q4 | $3.13M | Sell |
5,897
-255
| -4% | -$123K | 0.2% | 121 |
|
|
2023
Q3 | $3.12M | Sell |
6,152
-332
| -5% | -$177K | 0.22% | 115 |
|
|
2023
Q2 | $3.38M | Sell |
6,484
-173
| -3% | -$93.4K | 0.23% | 111 |
|
|
2023
Q1 | $3.84M | Sell |
6,657
-446
| -6% | -$251K | 0.27% | 99 |
|
|
2022
Q4 | $3.91M | Sell |
7,103
-757
| -10% | -$401K | 0.29% | 98 |
|
|
2022
Q3 | $3.99M | Sell |
7,860
-88
| -1% | -$49.2K | 0.32% | 92 |
|
|
2022
Q2 | $4.32M | Sell |
7,948
-68
| -0.8% | -$37.4K | 0.33% | 88 |
|
|
2022
Q1 | $4.74M | Sell |
8,016
-531
| -6% | -$305K | 0.33% | 84 |
|
|
2021
Q4 | $5.71M | Sell |
8,547
-70
| -0.8% | -$43.7K | 0.38% | 74 |
|
|
2021
Q3 | $4.92M | Buy |
8,617
+83
| +1% | +$45.6K | 0.37% | 78 |
|
|
2021
Q2 | $3.9M | Hold |
8,534
| – | – | 0.32% | 94 |
|
|
2021
Q1 | $3.9M | Sell |
8,534
-78
| -0.9% | -$37.2K | 0.32% | 94 |
|
|
2020
Q4 | $4.01M | Buy |
8,612
+433
| +5% | +$203K | 0.35% | 84 |
|
|
2020
Q3 | $3.61M | Buy |
8,179
+234
| +3% | +$96.7K | 0.31% | 89 |
|
|
2020
Q2 | $2.88M | Buy |
7,945
+200
| +3% | +$67K | 0.28% | 101 |
|
|
2020
Q1 | $2.2M | Buy |
7,745
+910
| +13% | +$287K | 0.25% | 108 |
|
|
2019
Q4 | $2.22M | Hold |
6,835
| – | – | 0.21% | 123 |
|
|
2019
Q3 | $1.99M | Buy |
6,835
+140
| +2% | +$40.1K | 0.2% | 121 |
|
|
2019
Q2 | $1.97M | Hold |
6,695
| – | – | 0.21% | 122 |
|
|
2019
Q1 | $1.83M | Buy |
6,695
+460
| +7% | +$114K | 0.2% | 125 |
|
|
2018
Q4 | $1.4M | Sell |
6,235
-350
| -5% | -$82.1K | 0.18% | 140 |
|
|
2018
Q3 | $1.61M | Hold |
6,585
| – | – | 0.17% | 143 |
|
|
2018
Q2 | $1.36M | Hold |
6,585
| – | – | 0.16% | 149 |
|
|
2018
Q1 | $1.36M | Sell |
6,585
-634
| -9% | -$133K | 0.16% | 145 |
|
|
2017
Q4 | $1.37M | Sell |
7,219
-150
| -2% | -$28.7K | 0.16% | 149 |
|
|
2017
Q3 | $1.39M | Hold |
7,369
| – | – | 0.17% | 147 |
|
|
2017
Q2 | $1.29M | Hold |
7,369
| – | – | 0.16% | 145 |
|
|
2017
Q1 | $1.13M | Sell |
7,369
-100
| -1% | -$15.3K | 0.15% | 149 |
|
|
2016
Q4 | $1.05M | Hold |
7,469
| – | – | 0.15% | 148 |
|
|
2016
Q3 | $1.19M | Sell |
7,469
-2,085
| -22% | -$321K | 0.18% | 143 |
|
|
2016
Q2 | $1.41M | Buy |
9,554
+2,419
| +34% | +$357K | 0.21% | 125 |
|
|
2016
Q1 | $1.01M | Hold |
7,135
| – | – | 0.15% | 153 |
|
|
2015
Q4 | $1.01M | Buy |
7,135
+80
| +1% | +$10.7K | 0.15% | 154 |
|
|
2015
Q3 | $862K | Buy |
7,055
+270
| +4% | +$35.2K | 0.14% | 162 |
|
|
2015
Q2 | $881K | Hold |
6,785
| – | – | 0.14% | 177 |
|
|
2015
Q1 | $911K | Hold |
6,785
| – | – | 0.14% | 175 |
|
|
2014
Q4 | $850K | Hold |
6,785
| – | – | 0.13% | 180 |
|
|
2014
Q3 | $826K | Hold |
6,785
| – | – | 0.13% | 178 |
|
|
2014
Q2 | $801K | Hold |
6,785
| – | – | 0.13% | 184 |
|
|
2014
Q1 | $816K | Sell |
6,785
-217
| -3% | -$25.8K | 0.14% | 177 |
|
|
2013
Q4 | $780K | Buy |
7,002
+42
| +0.6% | +$4.18K | 0.13% | 176 |
|
|
2013
Q3 | $641K | Sell |
6,960
-150
| -2% | -$13.6K | 0.12% | 185 |
|
|
2013
Q2 | $602K | Buy |
+7,110
| New | +$592K | 0.11% | 188 |
|
Other funds holding TMO
RG
LT
ATO
QP
CF
Leavell Investment Management's TMO Position: Q2 2026 in Review
Leavell Investment Management increased its Thermo Fisher Scientific (TMO) stake by 9.9% in Q2 2026, buying an estimated $252K and bringing the position to 5,835 shares worth $2.93M. The position accounts for 0.11% of the portfolio, ranked #182.
Leavell Investment Management first reported a position in TMO in Q2 2013 and has held it in 53 quarters since. The position peaked at $5.71M in Q4 2021. 794 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- Leavell Investment Management held 5,835 shares of Thermo Fisher Scientific worth $2.93M as of Q2 2026.
- Leavell Investment Management bought 524 Thermo Fisher Scientific shares in Q2 2026, an estimated $252K.
- Thermo Fisher Scientific made up 0.11% of Leavell Investment Management's portfolio in Q2 2026, its #182 holding.
- Leavell Investment Management first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 53 quarters since.
- Leavell Investment Management's Thermo Fisher Scientific position peaked at $5.71M in Q4 2021.
- 794 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on Leavell Investment Management's 13F filing for Q2 2026, filed 21 Jul 2026.